http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110903254-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-20
filingDate 2018-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110903254-B
titleOfInvention A kind of synthetic method applied to JAK inhibitor drug heterocyclic intermediate
abstract The application relates to a synthesis method for a heterocyclic intermediate of a JAK inhibitor drug, and relates to the field of synthesis of a drug intermediate. Specifically, it relates to a preparation method of a heterocycle synthesis JAK inhibitor intermediate, and provides a preparation method for synthesizing a compound of formula III through coupling and ring closure reactions. The compound of formula III can be applied to the synthesis of JAK inhibitor drugs such as urcitinib. The raw materials involved in the method of this application are easy to obtain and cheap, easy to operate, economical and environmentally friendly, and conducive to industrial production. .
priorityDate 2018-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408125873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448056355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453757390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450645223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422101152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341

Total number of triples: 37.